HIV and Women: PrEP Coverage

PrEP (pre-exposure prophylaxis) coverage is the estimated percentage of people with indications for PrEP classified as having been prescribed PrEP.

EHE goal: increase people classified as having been prescribed PrEP to 50 percent by 2025.

PrEP Coverage Among Women in the US, 2018*

PrEP is highly effective for preventing HIV from sex or injection drug use. 7 percent of women who could benefit from PrEP were prescribed PrEP in the US in 2018.
  1. CDC. Behavioral and clinical characteristics of persons with diagnosed HIV infection—Medical Monitoring Project, United States, 2018 cycle (June 2018–May 2019) pdf icon[PDF – 905 KB]HIV Surveillance Special Report 2020;25.
  2. CDC. Diagnoses of HIV infection in the United States and dependent areas, 2018 pdf icon[PDF – 7 MB]HIV Surveillance Report 2020;31.
  3. CDC. Estimated HIV incidence and prevalence in the United States, 2014-2018 pdf icon[PDF – 3 MB]HIV Surveillance Supplemental Report 2020;25(1).
  4. CDC. HIV infection risk, prevention, and testing behaviors among heterosexually active adults at increased risk for HIV infection–National HIV Behavioral Surveillance – 23 U.S. Cities, 2019 pdf icon[PDF – 3 MB]. HIV Surveillance Special Report 2021; 26.
  5. CDC. HIV infection risk, prevention, and testing behaviors among persons who inject drugs–National HIV Behavioral Surveillance: injection drug use – 23 U.S. Cities, 2018 pdf icon[PDF – 2 MB]. HIV Surveillance Special Report 2020; 24.
  6. CDC. HIV risk behaviors. Accessed January 28, 2020.
  7. CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2018 pdf icon[PDF – 4 MB]HIV Surveillance Supplemental Report 2020;25(2).
  8. CDC. Selected national HIV prevention and care outcomes pdf icon[PDF – 2 MB] [slides].
  9. CDC. Social determinants of health among adults with diagnosed HIV infection, 2018 pdf icon[PDF – 10 MB]. HIV Surveillance Supplemental Report 2020;25(3).
  10. CDC. Sexually transmitted disease surveillance, 2018. Accessed January 28, 2020.
  11. Bradley E, Forsberg K, Betts JE, et al. Factors affecting pre-exposure prophylaxis implementation for women in the United States: A systematic review. J Womens Health 2019;28(9):1272-85. PubMed abstractexternal icon.
  12. Evans ME, Tao G, Porter SE, Gray SC, Huang YA, Hoover KW. Low HIV testing rates among US women who report anal sex and other HIV sexual risk behaviors, 2011-2015. Am J Obstet Gynecol 2018;219(4):1-7. PubMed abstractexternal icon.
  13. McCree DH, Koenig LJ, Basile K, Fowler D, Green Y. Addressing the intersection of HIV and intimate partner violence among women with or at risk for HIV in the United States. J Womens Health 2015; 24(5):331-335. PubMed abstractexternal icon.
  14. Waldron M, Burnett-Zeigler I, Wee V, et al. Mental health in women living with HIV: The unique and unmet needs. J Int Assoc Provid AIDS Care 2021;20:1-18. PubMed abstractexternal icon.

View Page In:pdf icon PDF [2M]